PRESS RELEASE published on 02/14/2025 at 12:15, 1 year 6 months ago Franchissement de seuils Déclaration de franchissement de seuils par The Goldman Sachs Group, Inc. concernant les actions de la société EUROAPI sur Euronext Paris Euronext Paris Déclaration The Goldman Sachs Group, Inc. Franchissement De Seuils EUROAPI
BRIEF published on 02/11/2025 at 14:00, 1 year 7 months ago Goldman Sachs réduit sa participation dans EUROAPI Franchissement De Seuil Marché Boursier Goldman Sachs Cession D'actions EUROAPI
BRIEF published on 02/11/2025 at 14:00, 1 year 7 months ago Goldman Sachs reduces its stake in EUROAPI Stock Market Goldman Sachs Threshold Crossing Transfer Of Shares EUROAPI
PRESS RELEASE published on 02/11/2025 at 13:55, 1 year 7 months ago Franchissement de seuils Déclaration de franchissement de seuils de la société EUROAPI par The Goldman Sachs Group, Inc. le 31 janvier 2025 Déclaration AMF Franchissement De Seuils Goldman Sachs EUROAPI
BRIEF published on 01/31/2025 at 14:28, 1 year 7 months ago Threshold Crossings by The Goldman Sachs Group, Inc. at EUROAPI Actions Financial Market Goldman Sachs Crossing Thresholds EUROAPI
BRIEF published on 01/31/2025 at 14:28, 1 year 7 months ago Franchissements de seuils par The Goldman Sachs Group, Inc. chez EUROAPI Marché Financier Actions Franchissement De Seuils Goldman Sachs EUROAPI
PRESS RELEASE published on 01/31/2025 at 14:23, 1 year 7 months ago Franchissements de seuils Déclarations de franchissements de seuils par The Goldman Sachs Group, Inc. concernant EUROAPI, société cotée sur Euronext Paris Euronext Paris The Goldman Sachs Group, Inc. Franchissements De Seuils EUROAPI Déclarant
BRIEF published on 12/09/2024 at 20:22, 1 year 9 months ago EUROAPI Enters a New Chapter with Leadership Changes Pharmaceuticals 2024 Outlook Leadership Change EUROAPI FOCUS-27 Plan
BRIEF published on 12/09/2024 at 20:22, 1 year 9 months ago EUROAPI entre dans un nouveau chapitre avec des changements de direction Changement De Direction Perspectives 2024 Médicaments EUROAPI Plan FOCUS-27
PRESS RELEASE published on 12/09/2024 at 20:17, 1 year 9 months ago EUROAPI moves into a new chapter with new Governance and Leadership EUROAPI enters a new chapter with new Governance and Leadership as Emmanuel Blin becomes Independent Chair of the Board and David Seignolle appointed Chief Executive Officer, maintaining full-year 2024 guidance Governance Leadership EUROAPI Emmanuel Blin David Seignolle
Published on 09/12/2026 at 02:35, 11 hours 15 minutes ago Gamma Resources Announces Extension of Private Placement Closing Date
Published on 09/11/2026 at 23:00, 14 hours 50 minutes ago Rio Grande Resources Engages Machai Capital for Investor Outreach
Published on 09/11/2026 at 22:05, 15 hours 45 minutes ago Usha Resources Announces Leadership Transition
Published on 09/11/2026 at 21:25, 16 hours 25 minutes ago Algo Grande Copper Intersects 30.23 Metres Grading 1.5% CuEq, including 3.55 Metres at 9.4% CuEq and 1.2-Metre Interval at 15.8% CuEq, 100 Metres Vertical Step-Out from Historical Intersects
Published on 09/11/2026 at 17:00, 20 hours 50 minutes ago Critical Elements Selected for Canada Investment Summit Prospectus, Showcasing Project to Leading Global Investors
Published on 09/12/2026 at 07:30, 6 hours 20 minutes ago NAGRAVISION Secures Formula 1 Content for RTL Croatia and PRO PLUS Slovenia
Published on 09/11/2026 at 22:15, 15 hours 35 minutes ago Amrize Appoints Mario Gross as President of Building Envelope
Published on 09/11/2026 at 22:10, 15 hours 40 minutes ago Quantinuum to Participate in the Piper Sandler 5th Annual Growth Frontiers Conference
Published on 09/11/2026 at 19:44, 18 hours 6 minutes ago DocMorris announces final conversion price and issue size of its New Convertible Bonds due 2031
Published on 09/11/2026 at 18:15, 19 hours 35 minutes ago CGTN: How BRICS creates new opportunities for Global South development
Published on 09/11/2026 at 07:00, 1 day 6 hours ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 1 day 6 hours ago BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
Published on 09/10/2026 at 19:30, 1 day 18 hours ago Availability of the 2026 Interim Financial Report
